Core Scientific Stock News

Oaktree added 6.4 million shares of Core Scientific for an estimated $114.8 million in the third quarter. The Core Scientific position represents 1.8% of Oaktree's 13F reportable assets under management.

CoreWeave CEO Mike Intrator addressed delays at a third-party data center developer. CNBC's Jim Cramer noted delays at sites in Texas, Oklahoma and North Carolina tied to Core Scientific.

Core Scientific is rapidly transitioning from BTC mining to a leading AI HPC infrastructure provider, leveraging its 1.3 GW data center footprint. Initiate CORZ as a strong buy, citing undervaluation versus AI peers and significant upside as the market misprices it as a BTC miner. CORZ's AI hosting contracts deliver high-margin, recurring revenues, with projected explosive revenue growth and ex...

Infrastructure landlords with multiyear leases and fixed minimum payments offer revenue visibility that software-only AI plays lack. Companies that already operate data centers can convert existing sites to AI hosting faster than building new facilities from scratch.

Core Scientific shareholders on Thursday voted down an all-stock acquisition offer from partner and competitor CoreWeave that was valued at the time at $9 billion.

Core Scientific, Inc. shareholders rejected a $9B CoreWeave offer Thursday. We think this is the best thing that could've happened to Core Scientific. We see the potential for CORZ to grow into the valuation of its landlord peer group. There is more value in Core Scientific's uncontracted power capacity, and ballooning AI infrastructure demand can work in favor of leasing out its current 1.3 GW...

Core Scientific, Inc. ( CORZ ) Discusses Shareholder Vote and Termination of Proposed Merger October 30, 2025 11:30 AM EDT Company Participants Jon Charbonneau - Vice President of Investor Relations Adam Sullivan - CEO, President & Director Matt Brown - Chief Operating Officer Jim Nygaard - Chief Financial Officer Conference Call Participants Darren Aftahi - ROTH Capital Partners, LLC, Research...

Core Scientific trades at all-time highs ahead of a key shareholder vote on the proposed CoreWeave merger. The fixed exchange ratio undervalues CORZ shares, with the market speculating the deal will be blocked as peers like IREN and WULF outperform. Despite mixed Q3 results, CORZ's growth prospects in AI infrastructure and potential for new contracts remain strong if the merger is canceled.